TMBIM6 and hepatocellular carcinoma: To conclude, HCC-MSC-derived exosomal TMBIM6 promotes proliferation, invasion, sphere formation ability, and EMT via activating PI3K/AKT pathway in HCC, indicating that it could be a potential treatment target for HCC.